320MO A phase I clinical trial of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant MSS metastatic colorectal cancer (mCRC)
| العنوان: | 320MO A phase I clinical trial of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant MSS metastatic colorectal cancer (mCRC) |
|---|---|
| المؤلفون: | M.G. Fakih, J. Sandhu, D. Lim, S.M. Li, C. Wang |
| المصدر: | Annals of Oncology. 33:S684 |
| بيانات النشر: | Elsevier BV, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Oncology, Hematology |
| تدمد: | 0923-7534 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::5b13e9332f482037d0d38711da6afca3 https://doi.org/10.1016/j.annonc.2022.07.458 |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.doi...........5b13e9332f482037d0d38711da6afca3 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 09237534 |
|---|